This compound is primarily utilized in the synthesis of pharmaceutical intermediates, particularly in the development of beta-blockers, which are drugs used to manage cardiovascular conditions such as hypertension and arrhythmias. Its structure, featuring a difluorophenyl group, enhances the drug's binding affinity to beta-adrenergic receptors, improving efficacy. Additionally, it serves as a key building block in organic synthesis for creating compounds with potential central nervous system activity. Its applications also extend to research settings, where it is used to study receptor interactions and drug mechanisms.